Consumption of Thyroid Medications as an Indicator of Increase of Thyroid Morbidity in Latvia from 2011 to 2014

Anonymous (2012). 20. Vēstis [20th Proceedings]. The National Health Service of the Republic of Latvia (in Latvian). Available from: http://www.vmnvd.gov.lv/lv/publikacijas/vestis (accessed 15.05.2019).Search in Google Scholar

Anonymous (2014). Statistics On Medicines Consumption 2013. State Agency of Medicines. Available from: https://www.zva.gov.lv/sites/default/files/inline-files/zva-zstat-2013.pdf (accessed 15.05.2019).Search in Google Scholar

Anonymous (2015). 23. Vēstis [23th Proceedings]. The National Health Service of the Republic of Latvia (in Latvian). Available from: http://www.vmnvd.gov.lv/lv/publikacijas/vestis (accessed 15.05.2019).Search in Google Scholar

Anonymous (2017). Guidelines for ATC classification and DDD assignment 2018. WHO Collaborating Centre for Drug Statistics Methodology. Available from: https://www.whocc.no/filearchive/publications/guidelines.pdf (accessed 15.05.2019).Search in Google Scholar

Anonymous (2018a). Kopsavilkums par cukura diabēta pacientiem, 2001.–2017. [Summary about patients with diabetes mellitus, 2001.–2017.]. The Centre for Disease Prevention and Control (CDPC) of Latvia (in Latvian). Available from: https://www.spkc.gov.lv/lv/statistika-un-petijumi/statistika/veselibas-aprupes-statistika1 (accessed 15.05.2019).Search in Google Scholar

Anonymous (2018b). Statistics On Medicines Consumption 2017. State Agency of Medicines. Available from: https://www.zva.gov.lv/sites/deault/files/inline-files/zva-zstat-2013.pdf (accessed 15.05.2019).Search in Google Scholar

Bartalena, L., Bogazzi, F., Chiovato, L., Hubalewska-Dydejczyk, A., Links, T., Vanderpump, M. (2018). 2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dys-function. Eur. Thyroid J., 7 (2), 55–66.10.1159/000486957Search in Google Scholar

Carter, Y., Sippel, R. S., Chen, H. (2013). Hypothyroidism after a cancer diagnosis: Etiology, diagnosis, complications, and management. The Oncologist, 19 (1), 34–43.10.1634/theoncologist.2013-0237Search in Google Scholar

Hollowel, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., Braverman, L. E. (2002). Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab., 87 (2), 489–499.10.1210/jcem.87.2.8182Search in Google Scholar

Kahaly, G. J., Dietlein, M. (2002). Cost estimation of thyroid disorders in Germany. Thyroid, 12 (10), 909–914.10.1089/105072502761016548Search in Google Scholar

Koutras, D. A. (1997). Disturbances of menstruation in thyroid disease. Ann. New York Acad. Sci., 816 (1), 280–284.10.1111/j.1749-6632.1997.tb52152.xSearch in Google Scholar

Leo, S. D., Lee, S. Y., Braverman, L. E. (2016). Hyperthyroidism. The Lancet, 388 (10047), 906–918.10.1016/S0140-6736(16)00278-6Search in Google Scholar

Madariaga, A. G., Palacios, S. S., Guillén-Grima, F., Galofré, J. C. (2014). The incidence and prevalence of thyroid dysfunction in Europe: A meta-analysis. J. Clin. Endocrinol. Metab., 99 (3), 923–931.10.1210/jc.2013-2409Search in Google Scholar

Møllehave, L., Linneberg, A., Skaaby, T., Knudsen, N., Ehlers, L., Jørgensen, T., Thuesen, B. (2018). Trends in costs of thyroid disease treatment in Denmark during 1995–2015. Eur. Thyroid J.,7 (2), 75–83.10.1159/000485973Search in Google Scholar

Pearce, S. H., Brabant, G., Duntas, L. H., Monzani, F., Peeters, R. P., Razvi, S., Wemeau, J. (2013). 2013 ETA Guideline: Management of Subclinical Hypothyroidism. Eur. Thyroid J., 2 (4), 215–22810.1159/000356507Search in Google Scholar

Pirich, C., Müllner, M., Sinzinger, H. (2000). Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants. J. Clin. Epidemiol., 53 (6), 623–629.10.1016/S0895-4356(99)00187-0Search in Google Scholar

Rhee, C. M., Bhan, I., Alexander, E. K., Brunelli, S. M. (2012). Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch. Int. Med., 172 (2), 153.10.1001/archinternmed.2011.67722271121Search in Google Scholar

Rootslane L., Laius O., Sepp J., Kurvits K., Seilis A., Gailīte E., Ķikute D., Dr Gulbinovič J., Tomaševič R., Stasevičiūtė V. (2013). Baltic Statistics On Medicine 2010–2012. Estonian State Agency Of Medicines. Available from: http://www.ravimiamet.ee/sites/default/files/documents/publications/baltic_statistics_on_medicines_2010_2012/files/mobile/index.html#4 (accessed 15.05.2019).Search in Google Scholar

Seilis A., Gailīte E., Rootslane L., Laius O., Savaikis L., Tomaševič R. (2016). Baltic Statistics On Medicine 2013–2015. Estonian State Agency Of Medicines. Available from: https://www.zva.gov.lv/sites/default/files/2017-12/Baltic%20Statistics%20on%20Medicines%202013%20-%202015.pdf (accessed 15.05.2019).Search in Google Scholar

Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., Okosieme, O. E. (2018). Global epidemiology of hyperthyroidism and hypothyroidism. Nature Rev. Endocrinol.,14 (5), 301–316.10.1038/nrendo.2018.1829569622Search in Google Scholar

Vanderpump, M. P. (2011). The epidemiology of thyroid disease. Brit. Med. Bull.,99 (1), 39–51.10.1093/bmb/ldr03021893493Search in Google Scholar